SciBase Holding AB (publ) (STO:SCIB)

Market Cap	107.69M +29.1%
Revenue (ttm)	36.59M +36.2%
Net Income	-90.39M
EPS	-0.29
Shares Out	414.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,949
Average Volume	556,343
Open	0.2490
Previous Close	0.2600
Day's Range	0.2490 - 0.2600
52-Week Range	0.1850 - 0.5980
Beta	0.44
RSI	51.63
Earnings Date	Mar 13, 2026

About SciBase Holding AB

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Ne...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 38
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SCIB

Financial Performance

In 2024, SciBase Holding AB's revenue was 29.71 million, an increase of 27.79% compared to the previous year's 23.25 million. Losses were -61.13 million, 9.97% more than in 2023.